does semaglutide cause blindness Wegovy linked to rare “eye stroke” that can sudden Ozempic-Induced Blindness? A Measured Response

Indeed, CDER Acting Director Michael Davis reinforced the policy point publicly on X, emphasizing that compounded GLP1 products are not FDAapproved and have not undergone the rigorous review for safety, efficacy, and manufacturing quality that is required for drugs approved through the new drug application (NDA) or abbreviated new drug application (ANDA) pathways.[3] This is now the third major set of warning letters in less than a year with the majority aimed at telehealth marketing of compounded GLP-1 products: September 2025: roughly 80 warning letters and 40 untitled letters March 2026: 30 warning letters June 2026: 25 warning letters The Claims FDA Is Targeting As in earlier rounds, the June 2026 letters appear highly standardized and focus on consumerfacing promotion of compounded GLP-1 products

FAQs Will dry mouth affect the effectiveness of my GLP-1 treatment

Another online provider, Juniper, told patients in a blog post published in December 2025: Wegovy 7.2mg now delivers weight-loss outcomes (20.7%) almost identical to Mounjaro 15mg (20.9%), making it a cost-effective alternative amid rising Mounjaro prices. Mounjaro (tirzepatide

In this regard, histological studies reveal that there is a mild to moderate decline in the number of pigmented and tyrosine hydroxylase-positive neurons (1030% loss

Frequently asked questions Is glutathione the bodys main antioxidant